APO Research

APO RESEARCH · REPORT

Estradiol Patches

Selected research

Market Outlook & Growth Opportunities

Global Estradiol Patches Market Outlook and Growth Opportunities 2026

Market perspective

The global Estradiol Patches market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Estradiol Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Estradiol Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Estradiol Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Estradiol Patches market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Estradiol Patches market include Amneal Pharmaceuticals, Hisamitsu, Mylan, Noven, Theramex, AbbVie, Bayer, Novartis and Yatai Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Estradiol Patches market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Estradiol Patches and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Estradiol Patches sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Estradiol Patches market size, projected growth trends, production technologies, key applications, and end-use industries.

Estradiol Patches Segment by Company

Amneal Pharmaceuticals

Hisamitsu

Mylan

Noven

Theramex

AbbVie

Bayer

Novartis

Yatai Pharma

Estradiol Patches Segment by Type

Estradiol-only Patches

Combination Patches (Estradiol + Progestin)

Estradiol Patches Segment by Application

Post-Hysterectomy Therapy

Hormone Replacement Therapy (HRT) in Transgender Women

Menopause-Related Symptoms

Hypoestrogenism

Others

Estradiol Patches Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Estradiol Patches status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Estradiol Patches market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Estradiol Patches significant trends, drivers, influence factors in global and regions.

6. To analyze Estradiol Patches competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Estradiol Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Estradiol Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Estradiol Patches.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Estradiol Patches market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Estradiol Patches industry.

Chapter 3: Detailed analysis of Estradiol Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Estradiol Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Estradiol Patches in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Estradiol Patches Industry Trends Table 2. Estradiol Patches Industry Drivers Table 3. Estradiol Patches Industry Opportunities and Challenges Table 4. Estradiol Patches Industry Restraints Table 5. Global Estradiol Patches Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Estradiol Patches Revenue Share by Company (2021-2026) Table 7. Global Estradiol Patches Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Estradiol Patches Sales Volume Share by Company (2021-2026) Table 9. Global Estradiol Patches Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Estradiol Patches Company Ranking, (2024-2026) & (USD Million) Table 11. Global Estradiol Patches Key Company Manufacturing Base & Headquarters Table 12. Global Estradiol Patches Company, Product Type & Application Table 13. Global Estradiol Patches Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Estradiol Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Estradiol-only Patches Table 18. Significant Companies of Combination Patches (Estradiol + Progestin) Table 19. Global Estradiol Patches Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Estradiol Patches Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Estradiol Patches Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Estradiol Patches Sales Volume Share by Type (2021-2026) Table 23. Global Estradiol Patches Sales Volume Share by Type (2027-2032) Table 24. Global Estradiol Patches Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Estradiol Patches Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Estradiol Patches Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Estradiol Patches Sales Value Share by Type (2021-2026) Table 28. Global Estradiol Patches Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Post-Hysterectomy Therapy Table 30. Significant Companies of Hormone Replacement Therapy (HRT) in Transgender Women Table 31. Significant Companies of Menopause-Related Symptoms Table 32. Significant Companies of Hypoestrogenism Table 33. Significant Companies of Others Table 34. Global Estradiol Patches Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Estradiol Patches Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Estradiol Patches Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Estradiol Patches Sales Volume Share by Application (2021-2026) Table 38. Global Estradiol Patches Sales Volume Share by Application (2027-2032) Table 39. Global Estradiol Patches Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Estradiol Patches Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Estradiol Patches Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Estradiol Patches Sales Value Share by Application (2021-2026) Table 43. Global Estradiol Patches Sales Value Share by Application (2027-2032) Table 44. Global Estradiol Patches Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Estradiol Patches Sales by Region (2021-2026) & (K Units) Table 46. Global Estradiol Patches Sales Market Share by Region (2021-2026) Table 47. Global Estradiol Patches Sales by Region (2027-2032) & (K Units) Table 48. Global Estradiol Patches Sales Market Share by Region (2027-2032) Table 49. Global Estradiol Patches Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Estradiol Patches Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Estradiol Patches Sales Value Share by Region (2021-2026) Table 52. Global Estradiol Patches Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Estradiol Patches Sales Value Share by Region (2027-2032) Table 54. Global Estradiol Patches Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Estradiol Patches Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Estradiol Patches Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Estradiol Patches Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Estradiol Patches Sales by Country (2021-2026) & (K Units) Table 59. Global Estradiol Patches Sales Market Share by Country (2021-2026) Table 60. Global Estradiol Patches Sales by Country (2027-2032) & (K Units) Table 61. Global Estradiol Patches Sales Market Share by Country (2027-2032) Table 62. Global Estradiol Patches Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Estradiol Patches Sales Value Market Share by Country (2021-2026) Table 64. Global Estradiol Patches Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Estradiol Patches Sales Value Market Share by Country (2027-2032) Table 66. Amneal Pharmaceuticals Company Information Table 67. Amneal Pharmaceuticals Business Overview Table 68. Amneal Pharmaceuticals Estradiol Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Amneal Pharmaceuticals Estradiol Patches Product Portfolio Table 70. Amneal Pharmaceuticals Recent Development Table 71. Hisamitsu Company Information Table 72. Hisamitsu Business Overview Table 73. Hisamitsu Estradiol Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Hisamitsu Estradiol Patches Product Portfolio Table 75. Hisamitsu Recent Development Table 76. Mylan Company Information Table 77. Mylan Business Overview Table 78. Mylan Estradiol Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Mylan Estradiol Patches Product Portfolio Table 80. Mylan Recent Development Table 81. Noven Company Information Table 82. Noven Business Overview Table 83. Noven Estradiol Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Noven Estradiol Patches Product Portfolio Table 85. Noven Recent Development Table 86. Theramex Company Information Table 87. Theramex Business Overview Table 88. Theramex Estradiol Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Theramex Estradiol Patches Product Portfolio Table 90. Theramex Recent Development Table 91. AbbVie Company Information Table 92. AbbVie Business Overview Table 93. AbbVie Estradiol Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. AbbVie Estradiol Patches Product Portfolio Table 95. AbbVie Recent Development Table 96. Bayer Company Information Table 97. Bayer Business Overview Table 98. Bayer Estradiol Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Bayer Estradiol Patches Product Portfolio Table 100. Bayer Recent Development Table 101. Novartis Company Information Table 102. Novartis Business Overview Table 103. Novartis Estradiol Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Novartis Estradiol Patches Product Portfolio Table 105. Novartis Recent Development Table 106. Yatai Pharma Company Information Table 107. Yatai Pharma Business Overview Table 108. Yatai Pharma Estradiol Patches Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Yatai Pharma Estradiol Patches Product Portfolio Table 110. Yatai Pharma Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Estradiol Patches Distributors List Table 114. Estradiol Patches Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Estradiol Patches Product Image Figure 2. Global Estradiol Patches Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Estradiol Patches Sales Value (2021-2032) & (US$ Million) Figure 4. Global Estradiol Patches Sales (2021-2032) & (K Units) Figure 5. Global Estradiol Patches Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Estradiol Patches Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Estradiol-only Patches Image Figure 10. Combination Patches (Estradiol + Progestin) Image Figure 11. Global Estradiol Patches Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Estradiol Patches Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Estradiol Patches Sales Volume Share by Type (2021-2032) Figure 14. Global Estradiol Patches Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Estradiol Patches Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Estradiol Patches Sales Value Share by Type (2021-2032) Figure 17. Post-Hysterectomy Therapy Image Figure 18. Hormone Replacement Therapy (HRT) in Transgender Women Image Figure 19. Menopause-Related Symptoms Image Figure 20. Hypoestrogenism Image Figure 21. Others Image Figure 22. Global Estradiol Patches Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Estradiol Patches Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Estradiol Patches Sales Volume Share by Application (2021-2032) Figure 25. Global Estradiol Patches Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Estradiol Patches Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Estradiol Patches Sales Value Share by Application (2021-2032) Figure 28. Global Estradiol Patches Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Estradiol Patches Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Estradiol Patches Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Estradiol Patches Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Estradiol Patches Sales Value (2021-2032) & (US$ Million) Figure 33. North America Estradiol Patches Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Estradiol Patches Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Estradiol Patches Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Estradiol Patches Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Estradiol Patches Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Estradiol Patches Sales Value (2021-2032) & (US$ Million) Figure 39. South America Estradiol Patches Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Estradiol Patches Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Estradiol Patches Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Estradiol Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Estradiol Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Estradiol Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Estradiol Patches Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Estradiol Patches Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Estradiol-only Patches
  • Combination Patches (Estradiol + Progestin)
Applications
  • Post-Hysterectomy Therapy
  • Hormone Replacement Therapy (HRT) in Transgender Women
  • Menopause-Related Symptoms
  • Hypoestrogenism
  • Others
Companies covered
  • Amneal Pharmaceuticals
  • Hisamitsu
  • Mylan
  • Noven
  • Theramex
  • AbbVie
  • Bayer
  • Novartis
  • Yatai Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Estradiol Patches Sales Value (2021-2032)
  4. 1.2.2 Global Estradiol Patches Sales Volume (2021-2032)
  5. 1.2.3 Global Estradiol Patches Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Estradiol Patches Market Dynamics
  1. 2.1 Estradiol Patches Industry Trends
  2. 2.2 Estradiol Patches Industry Drivers
  3. 2.3 Estradiol Patches Industry Opportunities and Challenges
  4. 2.4 Estradiol Patches Industry Restraints
3 Estradiol Patches Market by Company
  1. 3.1 Global Estradiol Patches Company Revenue Ranking in 2025
  2. 3.2 Global Estradiol Patches Revenue by Company (2021-2026)
  3. 3.3 Global Estradiol Patches Sales Volume by Company (2021-2026)
  4. 3.4 Global Estradiol Patches Average Price by Company (2021-2026)
  5. 3.5 Global Estradiol Patches Company Ranking (2024-2026)
  6. 3.6 Global Estradiol Patches Company Manufacturing Base and Headquarters
  7. 3.7 Global Estradiol Patches Company Product Type and Application
  8. 3.8 Global Estradiol Patches Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Estradiol Patches Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Estradiol Patches Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Estradiol Patches Market by Type
  1. 4.1 Estradiol Patches Type Introduction
  2. 4.1.1 Estradiol-only Patches
  3. 4.1.2 Combination Patches (Estradiol + Progestin)
  4. 4.2 Global Estradiol Patches Sales Volume by Type
  5. 4.2.1 Global Estradiol Patches Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Estradiol Patches Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Estradiol Patches Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Estradiol Patches Sales Value by Type
  9. 4.3.1 Global Estradiol Patches Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Estradiol Patches Sales Value by Type (2021-2032)
  11. 4.3.3 Global Estradiol Patches Sales Value Share by Type (2021-2032)
5 Estradiol Patches Market by Application
  1. 5.1 Estradiol Patches Application Introduction
  2. 5.1.1 Post-Hysterectomy Therapy
  3. 5.1.2 Hormone Replacement Therapy (HRT) in Transgender Women
  4. 5.1.3 Menopause-Related Symptoms
  5. 5.1.4 Hypoestrogenism
  6. 5.1.5 Others
  7. 5.2 Global Estradiol Patches Sales Volume by Application
  8. 5.2.1 Global Estradiol Patches Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Estradiol Patches Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Estradiol Patches Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Estradiol Patches Sales Value by Application
  12. 5.3.1 Global Estradiol Patches Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Estradiol Patches Sales Value by Application (2021-2032)
  14. 5.3.3 Global Estradiol Patches Sales Value Share by Application (2021-2032)
6 Estradiol Patches Regional Sales and Value Analysis
  1. 6.1 Global Estradiol Patches Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Estradiol Patches Sales by Region (2021-2032)
  3. 6.2.1 Global Estradiol Patches Sales by Region: 2021-2026
  4. 6.2.2 Global Estradiol Patches Sales by Region (2027-2032)
  5. 6.3 Global Estradiol Patches Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Estradiol Patches Sales Value by Region (2021-2032)
  7. 6.4.1 Global Estradiol Patches Sales Value by Region: 2021-2026
  8. 6.4.2 Global Estradiol Patches Sales Value by Region (2027-2032)
  9. 6.5 Global Estradiol Patches Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Estradiol Patches Sales Value (2021-2032)
  12. 6.6.2 North America Estradiol Patches Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Estradiol Patches Sales Value (2021-2032)
  15. 6.7.2 Europe Estradiol Patches Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Estradiol Patches Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Estradiol Patches Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Estradiol Patches Sales Value (2021-2032)
  21. 6.9.2 South America Estradiol Patches Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Estradiol Patches Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Estradiol Patches Sales Value Share by Country, 2025 VS 2032
7 Estradiol Patches Country-level Sales and Value Analysis
  1. 7.1 Global Estradiol Patches Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Estradiol Patches Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Estradiol Patches Sales by Country (2021-2032)
  4. 7.3.1 Global Estradiol Patches Sales by Country (2021-2026)
  5. 7.3.2 Global Estradiol Patches Sales by Country (2027-2032)
  6. 7.4 Global Estradiol Patches Sales Value by Country (2021-2032)
  7. 7.4.1 Global Estradiol Patches Sales Value by Country (2021-2026)
  8. 7.4.2 Global Estradiol Patches Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Estradiol Patches Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Estradiol Patches Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Estradiol Patches Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Estradiol Patches Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Estradiol Patches Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Estradiol Patches Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Estradiol Patches Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Estradiol Patches Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Estradiol Patches Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Estradiol Patches Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Estradiol Patches Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Estradiol Patches Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Estradiol Patches Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Estradiol Patches Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Estradiol Patches Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Estradiol Patches Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Estradiol Patches Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Estradiol Patches Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Estradiol Patches Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Estradiol Patches Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Estradiol Patches Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Estradiol Patches Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Estradiol Patches Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Estradiol Patches Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Estradiol Patches Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Estradiol Patches Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Estradiol Patches Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Estradiol Patches Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Estradiol Patches Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Estradiol Patches Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Estradiol Patches Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Amneal Pharmaceuticals
  2. 8.1.1 Amneal Pharmaceuticals Company Information
  3. 8.1.2 Amneal Pharmaceuticals Business Overview
  4. 8.1.3 Amneal Pharmaceuticals Estradiol Patches Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Amneal Pharmaceuticals Estradiol Patches Product Portfolio
  6. 8.1.5 Amneal Pharmaceuticals Recent Developments
  7. 8.2 Hisamitsu
  8. 8.2.1 Hisamitsu Company Information
  9. 8.2.2 Hisamitsu Business Overview
  10. 8.2.3 Hisamitsu Estradiol Patches Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hisamitsu Estradiol Patches Product Portfolio
  12. 8.2.5 Hisamitsu Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Estradiol Patches Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Estradiol Patches Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Noven
  20. 8.4.1 Noven Company Information
  21. 8.4.2 Noven Business Overview
  22. 8.4.3 Noven Estradiol Patches Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Noven Estradiol Patches Product Portfolio
  24. 8.4.5 Noven Recent Developments
  25. 8.5 Theramex
  26. 8.5.1 Theramex Company Information
  27. 8.5.2 Theramex Business Overview
  28. 8.5.3 Theramex Estradiol Patches Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Theramex Estradiol Patches Product Portfolio
  30. 8.5.5 Theramex Recent Developments
  31. 8.6 AbbVie
  32. 8.6.1 AbbVie Company Information
  33. 8.6.2 AbbVie Business Overview
  34. 8.6.3 AbbVie Estradiol Patches Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 AbbVie Estradiol Patches Product Portfolio
  36. 8.6.5 AbbVie Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Estradiol Patches Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Estradiol Patches Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 Novartis
  44. 8.8.1 Novartis Company Information
  45. 8.8.2 Novartis Business Overview
  46. 8.8.3 Novartis Estradiol Patches Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Novartis Estradiol Patches Product Portfolio
  48. 8.8.5 Novartis Recent Developments
  49. 8.9 Yatai Pharma
  50. 8.9.1 Yatai Pharma Company Information
  51. 8.9.2 Yatai Pharma Business Overview
  52. 8.9.3 Yatai Pharma Estradiol Patches Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Yatai Pharma Estradiol Patches Product Portfolio
  54. 8.9.5 Yatai Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Estradiol Patches Value Chain Analysis
  2. 9.1.1 Estradiol Patches Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Estradiol Patches Sales Mode & Process
  6. 9.2 Estradiol Patches Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Estradiol Patches Distributors
  9. 9.2.3 Estradiol Patches Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research